George Simeon bought CRSP
October 14, 2026 · Form 4 insider transaction
George Simeon bought 30,000 shares of CRISPR Therapeutics AG at $14.00 per share, a transaction worth $420.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$14.00
Total value
$420.0K
InsiderGeorge Simeon
RoleDirector, 10% owner
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateOctober 14, 2026
Filing dateOctober 16, 2026
Shares owned after30,000
OwnershipDirect
10b5-1 planNo
AmendedNo